Drug Profile
Aptiganel
Alternative Names: CNS 1102Latest Information Update: 18 Dec 2001
Price :
$50
*
At a glance
- Originator CeNeS Pharmaceuticals
- Class Anti-ischaemics; Guanidines; Neuroprotectants
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Brain injuries; Stroke